Effects of intensive low-salt diet education on albuminuria among nondiabetic patients with hypertension treated with olmesartan: A single-blinded randomized, controlled trial

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 12, 2014, Pages 2059-2069

  Hwang, Jin Ho ^a   Chin, Ho Jun ^b   Kim, Sejoong ^b   Kim, Dong Ki ^c   Kim, Suhnggwon ^c   Park, Jung Hwan ^d   Shin, Sung Joon ^e   Lee, Sang Ho ^f   Choi, Bum Soon ^g   Lim, Chun Soo ^h  

^a Chung Ang University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d Konkuk University School of Medicine   (South Korea)

^e Dongguk University Ilsan Hospital   (South Korea)

^f Kyung Hee University College of Medicine   (South Korea)

^g The Catholic University of Korea   (South Korea)

^h Seoul National University Boramae Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; OLMESARTAN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; IMIDAZOLE DERIVATIVE; SODIUM; SODIUM INTAKE; TETRAZOLE DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ADULT; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; INTENSIVE LOW SALT DIET EDUCATION; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PATIENT COMPLIANCE; PATIENT EDUCATION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SALT INTAKE; SODIUM INTAKE; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; AGED; BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; COMPLICATION; FOOD; MEDICATION COMPLIANCE; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; SINGLE BLIND PROCEDURE; SODIUM RESTRICTION; URINE;

ADULT; AGED; ALBUMINURIA; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BLOOD PRESSURE; DIET, SODIUM-RESTRICTED; FEMALE; FOOD; HUMANS; HYPERTENSION; IMIDAZOLES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; RENAL INSUFFICIENCY, CHRONIC; SINGLE-BLIND METHOD; SODIUM; SODIUM, DIETARY; SURVEYS AND QUESTIONNAIRES; TETRAZOLES;

EID: 84922851808     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01310214     Document Type: Article

References (27)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296–1305, 2004
2. Madan P, Kalra OP, Agarwal S, Tandon OP: Cognitive impairment in chronic kidney disease. Nephrol Dial Transplant 22: 440–444, 2007
3. Locatelli F, Marcelli D, Comelli M, Alberti D, Graziani G, Buccianti G, Redaelli B, Giangrande A; Northern Italian Cooperative Study Group: Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Nephrol Dial Transplant 11: 461–467, 1996
4. Balamuthusamy S, Srinivasan L, Verma M, Adigopula S, Jalandhara N, Hathiwala S, Smith E: Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: A meta-analysis. Am Heart J 155: 791–805, 2008
5. Casas JP, Chua W, Loukogeorgakis S, Vallance P, Smeeth L, Hingorani AD, MacAllister RJ: Effect of inhibitors of the rennin-angiotensin system and other antihypertensive drugs on renal outcomes: Systematic review and meta-analysis. Lancet 366: 2026–2033, 2005
6. Vogt L, Waanders F, Boomsma F, de Zeeuw D, Navis G: Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol 19: 999–1007, 2008
7. Swift PA, Markandu ND, Sagnella GA, He FJ, MacGregor GA: Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: A randomized control trial. Hypertension 46: 308–312, 2005
8. He FJ, Marciniak M, Visagie E, Markandu ND, Anand V, Dalton RN, MacGregor GA: Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives. Hypertension 54: 482–488, 2009
9. Ekinci EI, Thomas G, Thomas D, Johnson C, Macisaac RJ, Houlihan CA, Finch S, Panagiotopoulos S, O’Callaghan C, Jerums G: Effects of salt supplementation on the albuminuric response to telmisartan with or without hydrochlorothiazide therapy in hypertensive patients with type 2 diabetes are modulated by habitual dietary salt intake. Diabetes Care 32: 1398–1403, 2009
10. Slagman MC, Waanders F, Hemmelder MH, Woittiez AJ, Janssen WM, Lambers Heerspink HJ, Navis G, Laverman GD; HOlland NEphrology STudy Group: Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: Randomised controlled trial. BMJ 343: d4366, 2011
11. Houlihan CA, Allen TJ, Baxter AL, Panangiotopoulos S, Casley DJ, Cooper ME, Jerums G: A low-sodium diet potentiates the effects of losartan in type 2 diabetes. Diabetes Care 25: 663–671, 2002
12. Allen TJ, Waldron MJ, Casley D, Jerums G, Cooper ME: Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes. Diabetes 46: 19–24, 1997
13. Vegter S, Perna A, Postma MJ, Navis G, Remuzzi G, Ruggenenti P: Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol 23: 165–173, 2012
14. Ying WZ, Sanders PW: Dietary salt enhances glomerular endothelial nitric oxide synthase through TGF-beta1. Am J Physiol 275: F18–F24, 1998
15. Chandramohan G, Bai Y, Norris K, Rodriguez-Iturbe B, Vaziri ND: Effects of dietary salt on intrarenal angiotensin system, NAD (P)H oxidase, COX-2, MCP-1 and PAI-1 expressions and NF-kappaB activity in salt-sensitive and -resistant rat kidneys. Am J Nephrol 28: 158–167, 2008
16. Kleinewietfeld M, Manzel A, Titze J, Kvakan H, Yosef N, Linker RA, Muller DN, Hafler DA: Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 496: 518–522, 2013
17. Wu C, Yosef N, Thalhamer T, Zhu C, Xiao S, Kishi Y, Regev A, Kuchroo VK: Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 496: 513–517, 2013
18. Ministry of Health and Welfare: Korea Health Statistics 2011: Korea National Health and Nutrition Examination Survey (KNHANES V-2), Seoul, South Korea, Ministry of Health and Welfare, 2012
19. Geleijnse JM, Kok FJ, Grobbee DE: Blood pressure response to changes in sodium and potassium intake: A metaregression analysis of randomised trials. J Hum Hypertens 17: 471–480, 2003
20. McMahon EJ, Bauer JD, Hawley CM, Isbel NM, Stowasser M, Johnson DW, Campbell KL: A randomized trial of dietary sodium restriction in CKD. J Am Soc Nephrol 24: 2096–2103, 2013
21. Kawasaki T, Uezono K, Itoh K, Ueno M: Prediction of 24-hour urinary creatinine excretion from age, body weight and height of an individual and its application. Nippon Koshu Eisei Zasshi 38: 567–574, 1991
22. Conlin PR, Chow D, Miller ER 3rd, Svetkey LP, Lin PH, Harsha DW, Moore TJ, Sacks FM, Appel LJ: The effect of dietary patterns on blood pressure control in hypertensive patients: Results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Hypertens 13: 949–955, 2000
23. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., Jones DW, Materson BJ, Oparil S, Wright JT Jr., Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289: 2560–2572, 2003
24. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia): Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349: 1857–1863, 1997
25. Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, Scolari F, Schena FP, Remuzzi G: Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 354: 359–364, 1999
26. Lambers Heerspink HJ, Holtkamp FA, Parving HH, Navis GJ, Lewis JB, Ritz E, de Graeff PA, de Zeeuw D: Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. Kidney Int 82: 330–337, 2012
27. He FJ, MacGregor GA: How far should salt intake be reduced? Hypertension 42: 1093–1099, 2003